How Can We Improve Our Immune Response to Cancer?

Dr. Patrick Hwu discusses Anti-PD-1 therapy in this episode of the Moffitt Medical Minute.

Can mRNA Vaccines Boost Effectiveness of CAR T-Cell Therapy?

Early trial results show response in solid tumors

Phase 2 Bladder Cancer Trial Shows Promising Results

Preliminary data were presented at 2022 AACR Annual Meeting

Is Adaptive Therapy in Prostate Cancer Patients a Promising Treatment?

Results of Moffitt-initiated phase 2a clinical trial suggest it can prolong cancer progression

Can Viruses Be Used to Treat Cancer?

Dr. Patrick Hwu tackles the answer in this Moffitt Medical Minute

UltraCAR-T™ Shows Promise for Treating Myeloid Malignancies

Fast-acting treatment aims to extend lives when minutes matter

Moffitt Study Shows Benefit to Giving CAR T-cell Therapy to Patients Sooner

Using cell therapy as a second-line treatment provided better outcomes for lymphoma patients compared to standard of care

Does Intensifying Lymphodepletion Impact CAR T-Cell Therapy?

Study investigates increasing duration and dosage of chemotherapy in patients with B-cell malignancies

Identifying Enhanced Response to Immunotherapy in Melanoma

New studies show gender and cancer origin can affect how well patients respond to treatment

Endeavor